Reviewed by: Nick Nicotra, Chief Science Officer
Safety & Efficacy Profile

Methylene Blue Safety & Efficacy

Evidence-based safety profile for methylene blue supplementation. This page provides a complete, transparent review of contraindications, drug interactions, dose-dependent side effects, and medical disclaimers — stated plainly.

If you are comparing methylene blue interactions with supplements, medications, or oral dosing formats, start here before choosing a brand or calculating a dose. Then review the third-party tested brand comparison and the USP-grade quality checklist.

Drug Interaction Table

According to published research, methylene blue is a potent, reversible inhibitor of monoamine oxidase A (MAO-A).[1] The following drug interactions are documented in peer-reviewed pharmacology literature and published case reports — they are not theoretical.

Methylene blue drug interactions by severity level
Drug ClassRisk LevelClinical OutcomeRecommendation
SSRIs / SNRIsSEVERESerotonin syndromeContraindicated
MAOIsSEVERESerotonin syndromeContraindicated
Serotonergic agents (triptans, tramadol, lithium, St. John's Wort, dextromethorphan)MODERATEElevated serotonin riskUse with caution; consult physician
Photosensitizing drugs (tetracyclines, fluoroquinolones)LOWEnhanced photosensitivityMonitor sun exposure

If you take any neurologically active prescription medication, consult your physician before use.[1]

Side Effects by Dose

Methylene blue exhibits a hormetic dose-response curve. Side effects are minimal within the therapeutic window and increase sharply above it.[5]

MILD / ADAPTIVE

0.5 – 1.0 mg/kg

  • ✓Blue-green urine (normal, harmless)
  • ✓Mild GI adjustment
  • ✓Temporary tongue staining if capsule opened
MODERATE

1.0 – 2.0 mg/kg

Most users remain in this range. Side effects may include headache, dizziness, mild anxiety, and nausea. These typically resolve within the first week of consistent use.

“Most safety studies use IV administration. Long-term safety data for oral MB supplementation is limited.”

TOXIC THRESHOLD

> 4.0 mg/kg

Doses above 4.0 mg/kg enter the toxic range. Risks include cardiovascular effects, hemolysis in susceptible individuals, methemoglobinemia, and serotonin toxicity when combined with serotonergic drugs. The dose-response curve inverts — methylene blue shifts from antioxidant to pro-oxidant.[3]

Normal vs. Stop Immediately

Expected & Harmless

  • ✓Blue-green urine — sign of active excretion
  • ✓Temporary tongue staining if capsule opened
  • ✓Mild nausea during the first few days
  • ✓Vivid or unusual dreams (reported anecdotally)
  • ✓Mild temporary energy increase

Stop Immediately — Consult Doctor

  • !Chest pain or difficulty breathing
  • !Severe headache or sudden vision changes
  • !Confusion, agitation, or rapid heartbeat
  • !High fever with muscle rigidity (serotonin syndrome signs) — see glossary
  • !Dark brown or chocolate-colored blood (methemoglobinemia) — see glossary
  • !Severe nausea, vomiting, or abdominal pain

Honest Limitations

  • Long-term safety data for oral methylene blue supplementation is limited. Most safety studies use IV administration in clinical settings. See our clinical trials page for available research.
  • Published human trials typically run 90 days or less. There are no multi-year randomized controlled trials of oral MB at supplement doses. Review the evidence.
  • Individual responses vary. What is well-tolerated in healthy adults may not apply to individuals with pre-existing conditions.[4]

Medical Disclaimer

Consult your healthcare provider before starting any new supplement, especially if you take prescription medications. The information on this page is for educational purposes only. It does not constitute medical advice and is not a substitute for professional medical consultation, diagnosis, or treatment.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary. This content reflects current scientific literature and does not represent regulatory approval of methylene blue for any indication.

Continue Reading

Safe dosing starts with understanding the mechanism. For practical next steps, see our guide on how to take methylene blue safely, explore the science, or follow our evidence-based 90-day protocol.

Read the ScienceView the 90-Day ProtocolMore Questions (FAQ)Medical Glossary

References

  1. [1]Ramsay RR, Dunford C, Gillman PK (2007). Methylene blue and serotonin toxicity: inhibition of monoamine oxidase A (MAO A) confirms a theoretical prediction. British Journal of Pharmacology. PMC1852086
  2. [2]Clifton J II, Leikin JB (2003). Methylene blue. American Journal of Therapeutics. PMC1351262
  3. [3]Oz M, Lorke DE, Hasan M, Bhatt GA (2011). Cellular and molecular actions of methylene blue in the nervous system. Medicinal Research Reviews. PMC3087269
  4. [4]Schirmer RH, Adler H, Pickhardt M, Mandelkow E (2011). "Lest we forget you — methylene blue..." — a historical review. Neurobiology of Aging. PMC3178874
  5. [5]Rojas JC, Bruchey AK, Gonzalez-Lima F (2012). Neurometabolic mechanisms for memory enhancement and neuroprotection of methylene blue. Progress in Neurobiology. PMC3345961
  6. [6]Stanford SC, Stanford BJ, Gillman PK (2000). Risk of severe serotonin toxicity following co-administration of methylene blue and serotonin reuptake inhibitors. CNS Drug Reviews. PMC1298087

Free: The Biohacker's 90-Day MB Protocol

Science-backed dosing schedule + stacking guide

  • 3-phase titration protocol (weeks 1-12)
  • Weight-based dosing tables
  • Synergistic stacking protocols
  • Biomarker tracking checklist

No spam. Unsubscribe anytime.